ECT, Acetylcholine Receptors, and Memory
Although almost fifty years have elapsed since its introduction, the basic mechanisms whereby electroconvulsive therapy (ECT) exerts its therapeutic effects, remain to be elucidated. The biological basis of ECT-induced memory impairment, the major adverse effect of anesthetic- and muscle relaxant-modified ECT, is also unknown.
KeywordsElectroconvulsive Therapy Retrograde Amnesia Inescapable Shock Electroconvulsive Shock Anterograde Amnesia
Unable to display preview. Download preview PDF.
- Deakin, J. F.W., Owen, F., Cross, A. J. and Dashwood, M. J., 1981, Studies on possible mechanisms of action of electroconvulsive therapy: Effects of repeated electrically induced seizurs on rat brain receptors for monoamines and other neurotransmitters. Psychopharmacology 73:345–349.PubMedCrossRefGoogle Scholar
- Deutch, J. A. and Rogers, J. B., 1979, Cholinergic excitability and memory: Animal studies and their clinical implications, in: “Brain Acetylcholine and Neuropsychiatric Disease,” K. L. Davis and P. A. Berger, eds., Plenum Press, New York.Google Scholar
- Grahame-Smith, D. G., Green, A. R., and Costain, D. W., 1978, Mechanism of the antidepressant action of electroconvulsive therapy, Lancet 1:245–256.Google Scholar
- Janowsky, D.S., El-Yousef, M. K., Davis, J. M., and Sekerk, H. J., 1972, A cholinergic-adrenergic hypothesis of mania and depression. Lancet 632–635.Google Scholar
- Kellar, K.J., Cascio, C.S., Bergstrom, D.A., Butler, J.A. and Iadarola, P., 1981, Electroconvulsive shock and reserpine: Effects on beta-adrenergic receptors in rat brain, J. Neuro- chem. 37:830–836.Google Scholar
- Lerer, B., Weiner, R.D. and Belmaker, R.H. (eds.), 1983, “ECT: Basic Mechanisms,” John Libbey, London.Google Scholar
- Lerer, B., Stanley, M., Demetriou, S., and Gershon, S., 1983, Effect of electroconvulsive shock on 3H-QNB binding in rat cerebral cortex and hippocampus, Journal of Neurochemistry, in press.Google Scholar
- Wastek, G.J. and Yamamura, H.I., 1978, Biochemical characterization of the muscarinic cholinergic receptor in human brain: Alterations in Huntington’s Disease. Mol. Pharmacol. Google Scholar